Susheel K. Kodali

Susheel K. Kodali's AcademicInfluence.com Rankings

Susheel K. Kodali

Engineering

#5414

World Rank

#6672

Historical Rank

Biomedical Engineering

#408

World Rank

#417

Historical Rank

engineering Degrees

Susheel K. Kodali

Philosophy

#7507

World Rank

#10730

Historical Rank

Logic

#4558

World Rank

#5868

Historical Rank

philosophy Degrees

Download Badge

Engineering
Philosophy

Susheel K. Kodali's Degrees

Doctorate Medicine Harvard University
PhD Biomedical Engineering Stanford University

Why Is Susheel K. Kodali Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Susheel K. Kodali's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. (2016) (3614)
Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients (2019) (2461)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1784)
Two-year outcomes after transcatheter or surgical aortic-valve replacement. (2012) (1727)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1700)
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial (2015) (1308)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (1192)
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. (2012) (1186)
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis (2016) (877)
Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. (2014) (755)
5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial (2015) (715)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). (2012) (642)
Two-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement (2013) (597)
Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. (2012) (527)
Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. (2013) (477)
Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. (2009) (472)
Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. (2012) (450)
Anatomical and Procedural Features Associated With Aortic Root Rupture During Balloon-Expandable Transcatheter Aortic Valve Replacement (2013) (447)
Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. (2015) (423)
The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. (2012) (412)
Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (2017) (407)
Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? A comprehensive review of the literature. (2013) (392)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) (388)
Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. (2015) (366)
Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement. (2020) (356)
Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement. (2017) (345)
Predictors of Mortality and Outcomes of Therapy in Low-Flow Severe Aortic Stenosis: A Placement of Aortic Transcatheter Valves (PARTNER) Trial Analysis (2013) (338)
Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. (2012) (317)
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis. (2017) (315)
Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis. (2014) (306)
Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. (2016) (301)
Health-Related Quality of Life After Transcatheter Aortic Valve Replacement in Inoperable Patients With Severe Aortic Stenosis (2011) (295)
Cost-Effectiveness of Transcatheter Aortic Valve Replacement Compared With Standard Care Among Inoperable Patients With Severe Aortic Stenosis: Results From the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort B) (2012) (271)
Transcatheter Aortic Valve Implantation Within Degenerated Aortic Surgical Bioprostheses: PARTNER 2 Valve-in-Valve Registry. (2017) (257)
1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification. (2018) (252)
Staging classification of aortic stenosis based on the extent of cardiac damage (2017) (246)
Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death. (2016) (221)
Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves). (2013) (219)
Early Feasibility Study of a Transcatheter Tricuspid Valve Annuloplasty: SCOUT Trial 30-Day Results. (2017) (210)
Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial). (2015) (207)
Predictors of Poor Outcomes After Transcatheter Aortic Valve Replacement: Results From the PARTNER (Placement of Aortic Transcatheter Valve) Trial (2014) (205)
Propensity-Matched Comparisons of Clinical Outcomes After Transapical or Transfemoral Transcatheter Aortic Valve Replacement: A Placement of Aortic Transcatheter Valves (PARTNER)-I Trial Substudy (2015) (200)
Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. (2014) (191)
Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. (2014) (186)
Quantity and location of aortic valve complex calcification predicts severity and location of paravalvular regurgitation and frequency of post-dilation after balloon-expandable transcatheter aortic valve replacement. (2014) (186)
Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation. (2019) (184)
Aortic valve and ascending aorta guidelines for management and quality measures. (2013) (181)
Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis. (2016) (172)
Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke. (2019) (166)
One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis (2016) (161)
Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study. (2017) (160)
Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry (2015) (159)
Prevalence, Significance, and Management of Aortic Insufficiency in Continuous Flow Left Ventricular Assist Device Recipients (2014) (158)
Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). (2014) (158)
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study. (2019) (155)
Aortic Annular Sizing Using a Novel 3-Dimensional Echocardiographic Method: Use and Comparison With Cardiac Computed Tomography (2014) (151)
Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. (2012) (149)
Long-Term Outcomes of Inoperable Patients With Aortic Stenosis Randomly Assigned to Transcatheter Aortic Valve Replacement or Standard Therapy (2014) (149)
Stroke associated with surgical and transcatheter treatment of aortic stenosis: a comprehensive review. (2011) (147)
Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve). (2013) (141)
Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve). (2014) (141)
Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial Wrap. (2018) (135)
Outcomes of Transcatheter and Surgical Aortic Valve Replacement in High-Risk Patients With Aortic Stenosis and Left Ventricular Dysfunction: Results From the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort A) (2013) (134)
Transcatheter Aortic Valve Replacement 2016: A Modern-Day "Through the Looking-Glass" Adventure. (2016) (133)
Impact of Preoperative Moderate/Severe Mitral Regurgitation on 2-Year Outcome After Transcatheter and Surgical Aortic Valve Replacement: Insight From the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A (2013) (131)
Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation. (2011) (124)
Transcatheter Aortic Valve Implantation: Anesthetic Considerations (2009) (124)
Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve (2017) (123)
Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves: PARTNER 3 Cardiac Computed Tomography Substudy. (2020) (122)
Insights Into Timing, Risk Factors, and Outcomes of Stroke and Transient Ischemic Attack After Transcatheter Aortic Valve Replacement in the PARTNER Trial (Placement of Aortic Transcatheter Valves) (2016) (122)
Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT. (2015) (121)
Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures. (2017) (120)
Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial. (2016) (117)
Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk. (2021) (116)
Chronic pacing and adverse outcomes after transcatheter aortic valve implantation (2015) (111)
Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis. (2020) (110)
Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR): Impact on Final Valve Orientation and Coronary Artery Overlap. (2020) (110)
Recommendations for comprehensive intraprocedural echocardiographic imaging during TAVR. (2015) (107)
Intercellular Calcium Waves in Neurons (1996) (105)
3-Year Outcomes After Valve-in-Valve Transcatheter Aortic Valve Replacement for Degenerated Bioprostheses: The PARTNER 2 Registry. (2019) (105)
Incidence and effect of acute kidney injury after transcatheter aortic valve replacement using the new valve academic research consortium criteria. (2013) (104)
A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery. (2015) (103)
Aortic valve and ascending aorta guidelines for management and quality measures: executive summary. (2013) (102)
Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk: Results From the PARTNER 2 Trial (2019) (96)
Repeat Transcatheter Aortic Valve Replacement for Transcatheter Prosthesis Dysfunction. (2020) (95)
Thirty-Day Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification (Valve-in-Mitral Annular Calcification) in the United States (2020) (95)
Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial (2017) (94)
Long-Term Valve Performance of TAVR and SAVR: A Report From the PARTNER I Trial. (2016) (92)
Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve). (2014) (92)
Aortic stenosis and coronary artery disease: what do we know? What don't we know? A comprehensive review of the literature with proposed treatment algorithms. (2014) (89)
Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial). (2011) (89)
Impact of Aortic Annulus Size on Valve Hemodynamics and Clinical Outcomes After Transcatheter and Surgical Aortic Valve Replacement: Insights From the PARTNER Trial (2014) (85)
Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System: A Multicenter, Observational, First-in-Human Experience. (2021) (81)
Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve). (2014) (81)
One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart Valve. (2020) (81)
New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial. (2019) (80)
Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation. (2021) (79)
The impact of calcium volume and distribution in aortic root injury related to balloon-expandable transcatheter aortic valve replacement. (2015) (78)
Simulations of transcatheter aortic valve implantation: implications for aortic root rupture (2015) (78)
Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial. (2020) (78)
Sex-Specific Differences at Presentation and Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement (2016) (76)
A novel approach to percutaneous right-ventricular mechanical support. (2012) (76)
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative. (2017) (75)
Indications for and Findings on Transthoracic Echocardiography in COVID-19 (2020) (75)
Approach to Acute Cardiovascular Complications in COVID-19 Infection. (2020) (74)
Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis (2019) (73)
A Cardiac Computed Tomography-Based Score to Categorize Mitral Annular Calcification Severity and Predict Valve Embolization. (2020) (72)
Dual catheter technique for the treatment of severe coronary artery perforations (2010) (71)
Trends in Complications and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Experience From the PARTNER Continued Access Registry. (2016) (70)
Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device. (2019) (70)
Atrial Fibrillation Is Associated With Increased Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the Placement of Aortic Transcatheter Valve (PARTNER) Trial (2016) (69)
Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER trial). (2013) (67)
Predicting paravalvular regurgitation following transcatheter valve replacement: utility of a novel method for three-dimensional echocardiographic measurements of the aortic annulus. (2013) (67)
Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial (2017) (67)
Transapical and Transaortic Transcatheter Aortic Valve Replacement in the United States. (2015) (65)
Gait Speed and Dependence in Activities of Daily Living in Older Adults With Severe Aortic Stenosis (2012) (65)
Transcatheter versus surgical aortic valve replacement in patients with diabetes and severe aortic stenosis at high risk for surgery: an analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve). (2014) (65)
Acquired thrombocytopenia after transcatheter aortic valve replacement: clinical correlates and association with outcomes. (2014) (65)
Costs of Periprocedural Complications in Patients Treated With Transcatheter Aortic Valve Replacement: Results From the Placement of Aortic Transcatheter Valve Trial (2014) (64)
Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER Trial. (2016) (64)
Propensity-Matched Comparisons of Clinical Outcomes after Transapical or Transfemoral TAVR: A PARTNER-I Trial Substudy (2015) (64)
Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis. (2016) (63)
Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons. (2014) (62)
Outcome and improvement predictors of mitral regurgitation after transcatheter aortic valve implantation. (2011) (61)
Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention. (2008) (61)
Valvular Heart Disease in Patients ≥80 Years of Age. (2018) (61)
Transcatheter aortic valve implantation: 10-year anniversary part II: clinical implications. (2012) (59)
Practices and complications of vascular closure devices and manual compression in patients undergoing elective transfemoral coronary procedures. (2012) (59)
Transatrial implantation of a transcatheter heart valve for severe mitral annular calcification (2018) (58)
Operator Experience and Procedural Results of Transcatheter Mitral Valve Repair in the United States. (2019) (58)
Independent impact of extent of coronary artery disease and percutaneous revascularisation on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results. (2018) (57)
Infective Endocarditis After Transcatheter Aortic Valve ImplantationCLINICAL PERSPECTIVE (2015) (56)
Impact of Coronary Artery Disease Severity Assessed With the SYNTAX Score on Outcomes Following Transcatheter Aortic Valve Replacement (2017) (56)
Efficacy and Safety of Postdilatation to Reduce Paravalvular Regurgitation During Balloon-Expandable Transcatheter Aortic Valve Replacement (2013) (56)
Early Single-Site Experience With Transcatheter Tricuspid Valve Replacement. (2019) (55)
Prosthetic Valve Endocarditis after TAVR and SAVR: Insights from the PARTNER Trials. (2019) (55)
Transcatheter Aortic Valve Replacement in Oncology Patients With Severe Aortic Stenosis. (2019) (55)
Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis (2020) (54)
Impact of Short-Term Complications on Mortality and Quality of Life After Transcatheter Aortic Valve Replacement. (2019) (54)
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative (2018) (52)
Proposal for a Standard Echocardiographic Tricuspid Valve Nomenclature. (2021) (52)
Overexpansion of the SAPIEN 3 Transcatheter Heart Valve: A Feasibility Study. (2015) (52)
Computed Tomography-Based Oversizing Degrees and Incidence of Paravalvular Regurgitation of a New Generation Transcatheter Heart Valve. (2017) (52)
iCoapsys mitral valve repair system: Percutaneous implantation in an animal model (2008) (52)
Intraprocedural Imaging of Transcatheter Tricuspid Valve Interventions. (2019) (51)
Mechanisms and Patterns of Intravascular Ultrasound In-Stent Restenosis Among Bare Metal Stents and First- and Second-Generation Drug-Eluting Stents. (2015) (51)
Evaluation of Flow After Transcatheter Aortic Valve Replacement in Patients With Low-Flow Aortic Stenosis: A Secondary Analysis of the PARTNER Randomized Clinical Trial. (2016) (50)
Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients (2020) (49)
Outcomes for the Commercial Use of Self-Expanding Prostheses in Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry. (2017) (49)
Transcatheter aortic valve replacement in patients with critical aortic stenosis: rationale, device descriptions, early clinical experiences, and perspectives. (2006) (48)
Early Multinational Experience of Transcatheter Tricuspid Valve Replacement for Treating Severe Tricuspid Regurgitation. (2020) (48)
In vitro evaluation of implantation depth in valve-in-valve using different transcatheter heart valves. (2016) (46)
Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial. (2017) (46)
Health Status after Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis. (2019) (43)
Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial. (2018) (43)
Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era. (2008) (43)
Clinical and Functional Outcomes Associated With Myocardial Injury After Transfemoral and Transapical Transcatheter Aortic Valve Replacement: A Subanalysis From the PARTNER Trial (Placement of Aortic Transcatheter Valves). (2015) (40)
Transcatheter aortic valve replacement and standard therapy in inoperable patients with aortic stenosis and low EF (2015) (40)
Modeling Left Ventricular Blood Flow Using Smoothed Particle Hydrodynamics (2017) (40)
Outcomes in Nonagenarians Undergoing Transcatheter Aortic Valve Replacement in the PARTNER-I Trial. (2015) (40)
Association of Transcatheter Aortic Valve Replacement With 30-Day Renal Function and 1-Year Outcomes Among Patients Presenting With Compromised Baseline Renal Function: Experience From the PARTNER 1 Trial and Registry (2017) (38)
Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER Trial). (2015) (38)
Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation. (2019) (38)
Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts. (2018) (38)
Expanding the indications for transcatheter aortic valve implantation (2019) (38)
Transcatheter Replacement of Transcatheter Versus Surgically Implanted Aortic Valve Bioprostheses. (2021) (38)
Comparison of a Complete Percutaneous versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results from the Randomized SURTAVI Trial. (2019) (37)
The Effect and Relationship of Frailty Indices on Survival After Transcatheter Aortic Valve Replacement. (2020) (37)
Numerical Parametric Study of Paravalvular Leak Following a Transcatheter Aortic Valve Deployment Into a Patient-Specific Aortic Root. (2018) (37)
Impact of the COVID‐19 pandemic on interventional cardiology fellowship training in the New York metropolitan area: A perspective from the United States epicenter (2020) (37)
Case Volume and Outcomes After TAVR With Balloon-Expandable Prostheses: Insights From TVT Registry. (2019) (36)
Injuries to the Aorta, Aortic Annulus, and Left Ventricle During Transcatheter Aortic Valve Replacement: Management and Outcomes. (2017) (36)
Echocardiographic imaging of procedural complications during balloon-expandable transcatheter aortic valve replacement. (2015) (35)
CT-Defined Prosthesis-Patient Mismatch Downgrades Frequency and Severity, and Demonstrates No Association With Adverse Outcomes After Transcatheter Aortic Valve Replacement. (2017) (35)
Restructuring Structural Heart Disease Practice During the COVID-19 Pandemic (2020) (35)
Transcatheter Valve Implantation in Failed Surgically Inserted Bioprosthesis: Review and Practical Guide to Echocardiographic Imaging in Valve-in-Valve Procedures. (2015) (33)
Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Repair. (2022) (32)
Optimizing Cardiac CT Protocols for Comprehensive Acquisition Prior to Percutaneous MV and TV Repair/Replacement. (2020) (32)
Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During Transcatheter Aortic Valve Replacement. (2018) (31)
Very low intravenous contrast volume protocol for computed tomography angiography providing comprehensive cardiac and vascular assessment prior to transcatheter aortic valve replacement in patients with chronic kidney disease. (2016) (31)
Impact of Aortic Root Anatomy and Geometry on Paravalvular Leak in Transcatheter Aortic Valve Replacement With Extremely Large Annuli Using the Edwards SAPIEN 3 Valve. (2018) (31)
Core Competencies in Echocardiography for Imaging Structural Heart Disease Interventions: An Expert Consensus Statement. (2019) (30)
Early Feasibility Study of Cardioband Tricuspid System for Functional Tricuspid Regurgitation: 30-Day Outcomes. (2021) (30)
Impact of Transcatheter Aortic Valve Replacement on Severity of Chronic Kidney Disease. (2020) (30)
Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement. (2019) (30)
Impact of Massive or Torrential Tricuspid Regurgitation in Patients Undergoing Transcatheter Tricuspid Valve Intervention. (2020) (30)
Finite Element Analysis of Tricuspid Valve Deformation from Multi-slice Computed Tomography Images (2018) (29)
Practical determination of aortic valve calcium volume score on contrast-enhanced computed tomography prior to transcatheter aortic valve replacement and impact on paravalvular regurgitation: Elucidating optimal threshold cutoffs. (2017) (28)
Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement (2015) (28)
Periaortic hematoma after transcatheter aortic valve replacement: Description of a new complication (2012) (28)
Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry. (2014) (28)
Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries. (2019) (27)
Outcomes of Prosthesis-Patient Mismatch Following Supra-Annular Transcatheter Aortic Valve Replacement: From the STS/ACC TVT Registry. (2021) (26)
Comparison between Three‐Dimensional Echocardiography and Computed Tomography for Comprehensive Tricuspid Annulus and Valve Assessment in Severe Tricuspid Regurgitation: Implications for Tricuspid Regurgitation Grading and Transcatheter Therapies (2018) (26)
Prospective Evaluation of Transseptal TMVR for Failed Surgical Bioprostheses: MITRAL Trial Valve-in-Valve Arm 1-Year Outcomes. (2021) (26)
Procedural variation in the performance of primary percutaneous coronary intervention for ST‐elevation myocardial infarction: A SCAI‐based survey study of US interventional cardiologists (2014) (26)
Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke Among Patients at Low Surgical Risk. (2021) (26)
Value of drug-eluting stents in cardiac transplant recipients. (2009) (25)
Prospective Study of TMVR Using Balloon-Expandable Aortic Transcatheter Valves in MAC: MITRAL Trial 1-Year Outcomes. (2021) (25)
Outcomes of TTVI in Patients With Pacemaker or Defibrillator Leads: Data From the TriValve Registry. (2020) (25)
Impact of Methodologic Differences in Three‐Dimensional Echocardiographic Measurements of the Aortic Annulus Compared with Computed Tomographic Angiography Before Transcatheter Aortic Valve Replacement (2017) (24)
Comparison of Transcatheter and Surgical Aortic Valve Replacement in Severe Aortic Stenosis: A Longitudinal Study of Echo Parameters in Cohort A of the PARTNER Trial (2013) (24)
Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry. (2021) (24)
Outcomes in 937 Intermediate-Risk Patients Undergoing Surgical Aortic Valve Replacement in PARTNER-2A. (2017) (24)
Dimensional Analysis of Aortic Root Geometry During Diastole Using 3D Models Reconstructed from Clinical 64-Slice Computed Tomography Images (2011) (23)
Transcatheter Aortic and Mitral Valve‐in‐Valve Implantation Using the Edwards Sapien 3 Heart Valve (2018) (23)
Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials. (2019) (23)
Patient selection for transcatheter aortic valve replacement. (2013) (22)
Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement: A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy (2015) (22)
Practical considerations for optimizing cardiac computed tomography protocols for comprehensive acquisition prior to transcatheter aortic valve replacement. (2016) (22)
Patient radiation exposure during transcatheter aortic valve replacement procedures. (2012) (21)
Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial. (2018) (20)
Important role of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock. (2015) (20)
A randomized evaluation of the TriGuard™ HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial. (2021) (20)
Intracardiac vs transesophageal echocardiography for percutaneous left atrial appendage occlusion: A meta‐analysis (2019) (20)
Paravalvular leak after transcatheter aortic valve replacement. (2013) (19)
CT image-based engineering analysis of transcatheter aortic valve replacement. (2014) (19)
Comparison of Local Versus General Anesthesia Following Transfemoral Transcatheter Self-Expanding Aortic Valve Implantation (from the Transcatheter Valve Therapeutics Registry). (2019) (19)
Transcatheter aortic valve replacement and vascular complications definitions. (2014) (19)
Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry. (2019) (19)
Thirty-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results. (2021) (18)
Prospective Evaluation of TMVR for Failed Surgical Annuloplasty Rings: MITRAL Trial Valve-in-Ring Arm 1-Year Outcomes. (2021) (18)
Transcatheter Aortic Valve Replacement by a Novel Suprasternal Approach. (2018) (18)
Age alone should not preclude surgery: contemporary outcomes after aortic valve replacement in nonagenarians. (2014) (18)
Randomized Comparison of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients. (2022) (17)
EARLY FEASIBILITY STUDY OF CARDIOBAND TRICUSPID SYSTEM FOR FUNCTIONAL TRICUSPID REGURGITATION: 30 DAY OUTCOMES (2020) (17)
Transcatheter tricuspid valve-in-valve replacement resulting in 4 different prosthetic heart valves in a single patient. (2013) (17)
Aortic Valve Annular Sizing: Intraoperative Assessment Versus Preoperative Multidetector Computed Tomography (2017) (17)
Coronary artery disease and aortic stenosis in the transcatheter aortic valve replacement era: old questions, new paradigms: the evolving role of percutaneous coronary intervention in the treatment of patients with aortic stenosis. (2012) (16)
Mid-Term Outcomes of Transcatheter Aortic Valve Replacement in Extremely Large Annuli With Edwards SAPIEN 3 Valve. (2019) (16)
Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement. (2022) (16)
Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation: TRISCEND Study 30-Day Results. (2022) (15)
Transcatheter Tricuspid Valve Replacement With the EVOQUE System: 1-Year Outcomes of a Multicenter, First-in-Human Experience. (2022) (15)
Transcatheter Mitral Valve Replacement: Design Implications, Potential Pitfalls and Outcomes Assessment (2015) (15)
Postoperative Atrial Fibrillation or Flutter Following Transcatheter or Surgical Aortic Valve Replacement: PARTNER 3 Trial. (2021) (15)
The International Society for Minimally Invasive Cardiothoracic Surgery Expert Consensus Statement on Transcatheter and Surgical Aortic Valve Replacement in Low- and Intermediate-Risk Patients: A Meta-Analysis of Randomized and Propensity-Matched Studies (2021) (15)
Self-Expanding Valve System for Treatment of Native Aortic Regurgitation by Transcatheter Aortic Valve Implantation (from the STS/ACC TVT Registry). (2019) (14)
Cerebral Embolic Risk During Transcatheter Mitral Valve Interventions: An Unaddressed and Unmet Clinical Need? (2018) (14)
Leadless pacemaker implantation: A feasible and reasonable option in transcatheter heart valve replacement patients (2019) (13)
Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry. (2020) (13)
"Predictors of pacemaker implantation after TAVI according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis". (2020) (13)
The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 Registry. (2018) (13)
Feasibility and Early Safety of Single-Stage Hybrid Coronary Intervention and Valvular Cardiac Surgery. (2015) (13)
Neurocognition and Cerebral Lesion Burden in High-Risk Patients Before Undergoing Transcatheter Aortic Valve Replacement: Insights From the SENTINEL Trial. (2018) (13)
Invasive Right Ventricular Pressure-Volume Analysis: Basic Principles, Clinical Applications, and Practical Recommendations (2021) (13)
The PARTNER 3 Bicuspid Registry for Transcatheter Aortic Valve Replacement in Low-Surgical-Risk Patients. (2022) (12)
Impact of recent heart failure hospitalization on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis from the PARTNER 2 trial and registries (2020) (12)
Current Generation Balloon-Expandable Transcatheter Valve Positioning Strategies During Aortic Valve-in-Valve Procedures and Clinical Outcomes. (2019) (12)
Clinical impact of mitral calcium volume in patients undergoing transcatheter aortic valve implantation. (2020) (12)
Association of Statin Use and Mortality After Transcatheter Aortic Valve Replacement (2019) (12)
Atrial Fibrillation is Associated with Increased Pacemaker Implantation Rates in the Placement of AoRTic Transcatheter Valve (PARTNER) Trial. (2017) (11)
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial. (2018) (11)
Derivation and external validation of a simple risk tool to predict 30-day hospital readmissions after transcatheter aortic valve replacement. (2019) (11)
Transcatheter Tricuspid Valve‐in‐Valve Intervention for Degenerative Bioprosthetic Tricuspid Valve Disease (2017) (11)
Suprasternal and Left Axillary Transcatheter Aortic Valve Replacement in Morbidly Obese Patients. (2018) (11)
Imaging in patients with severe mitral annular calcification: insights from a multicentre experience using transatrial balloon-expandable valve replacement. (2019) (11)
Trends in Transcatheter and Surgical Aortic Valve Replacement Among Older Adults in the United States. (2021) (11)
Improving the accuracy of effective orifice area assessment after transcatheter aortic valve replacement: validation of left ventricular outflow tract diameter and pulsed-wave Doppler location and impact of three-dimensional measurements. (2015) (10)
Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation. (2022) (10)
Concomitant transcatheter aortic and mitral valve-in-valve replacements using transfemoral devices via the transapical approach: first case in United States. (2013) (10)
Restructuring Electrophysiology During the COVID-19 Pandemic: A Practical Guide From a New York City Hospital Network (2020) (10)
Paravalvular Regurgitation Following Transcutaneous Aortic Valve Replacement: Predictors and Clinical Significance (2014) (10)
Transcatheter Tricuspid Valve Intervention in Patients With Right Ventricular Dysfunction or Pulmonary Hypertension: Insights From the TriValve Registry. (2021) (10)
Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial. (2020) (10)
Mitral valve-in-valve and valve-in-ring: tips, tricks, and outcomes. (2021) (9)
Use of stented bovine pericardial valve for surgical mitral valve replacement in infants. (2016) (9)
Long-Term Outcomes After Infective Endocarditis After Transcatheter Aortic Valve Replacement. (2020) (9)
Echocardiographic assessment of pressure volume relations in heart failure and valvular heart disease: using imaging to understand physiology. (2011) (9)
Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve Replacement. (2021) (9)
Surgical and Transcatheter Mitral Valve Replacement in Mitral Annular Calcification: A Systematic Review (2021) (8)
The initial U.S. experience with the Tempo active fixation temporary pacing lead in structural heart interventions (2020) (8)
- year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis ( PARTNER 1 ) : a randomised controlled trial (2015) (8)
Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial. (2022) (8)
Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement. (2021) (8)
REDUCED INCIDENCE OF PROSTHESIS–PATIENT MISMATCH AND ITS SEQUELAE IN TRANSCATHETER VERSUS SURGICAL VALVE REPLACEMENT IN HIGH–RISK PATIENTS WITH SEVERE AORTIC STENOSIS: A PARTNER TRIAL COHORT A ANALYSIS (2013) (8)
Cerebrovascular events after transcatheter mitral valve interventions: a systematic review and meta-analysis (2020) (8)
Relationship Between Accelerometer-Measured Activity and Self-Reported or Performance-Based Function in Older Adults with Severe Aortic Stenosis (2015) (8)
Contemporary suprasternal transcatheter aortic valve replacement: A multicenter experience using a simple, reliable alternative access approach (2020) (7)
Exploring the Reduction in Hospitalization Costs Associated with Next-Day Discharge following Transfemoral Transcatheter Aortic Valve Replacement in the United States (2019) (7)
TCT-88 6-Month Outcomes of an Early Feasibility Study of the AccuCinch Left Ventricular Repair System in Patients With Heart Failure and Functional Mitral Regurgitation (2019) (7)
Accuracy of the Single Cycle Length Method for Calculation of Aortic Effective Orifice Area in Irregular Heart Rhythms (2019) (7)
Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart Disease. (2022) (7)
5-Year Follow-Up From the PARTNER 2 Aortic Valve-in-Valve Registry for Degenerated Aortic Surgical Bioprostheses. (2022) (7)
Inter- and intrasite variability of mortality and stroke for sites performing both surgical and transcatheter aortic valve replacement for aortic valve stenosis in intermediate-risk patients. (2020) (7)
Early Clinical Outcomes After Transcatheter€Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis€in€Patients With Severe€Aortic€Stenosis Who Are Suboptimal€for€Surgery (7)
Aortic valve replacement vs. balloon-expandable and self-expandable transcatheter implantation: A network meta-analysis. (2021) (6)
Impact of Annular Oversizing on Paravalvular Regurgitation and Valve Hemodynamics: New Insights From PARTNER 3. (2021) (6)
Readmission for Acute Decompensated Heart Failure among Patients Successfully Treated with Transcatheter Aortic Valve Replacement: A PARTNER-1 Substudy (2018) (6)
Transcatheter aortic valve replacement: The year in review 2016 (2017) (6)
Paravalvular Regurgitation Post-Transcatheter Aortic Valve Replacement in Intermediate Risk Patients: A Pooled PARTNER 2 Study. (2021) (6)
Transcatheter aortic valve replacement: game-changing innovation for patients with aortic stenosis. (2014) (6)
Transcatheter Tricuspid Repair With the Use of 4-Dimensional Intracardiac Echocardiography. (2021) (6)
Transcatheter valve repair and replacement. (2009) (6)
RATES OF PARAVALVULAR AORTIC REGURGITATION WITH MDCT NOMINAL AREA OVERSIZING OR UNDERSIZING AFTER TRANSCATHETER HEART VALVE REPLACEMENT WITH THE SAPIEN 3: A COMPARISON WITH THE SAPIEN XT (2014) (6)
Mitraclip Followed by Surgical Aortic Valve Replacement: Hybrid Techniques for Regurgitant Aortic and Mitral Valve Disease. (2016) (5)
Anatomic classification of mitral annular calcification for surgical and transcatheter mitral valve replacement (2021) (5)
SURGICAL AND TRANSCATHETER MITRAL VALVE REPLACEMENT IN MITRAL ANNULAR CALCIFICATION- A SYSTEMATIC REVIEW (2020) (5)
State-of-the-art intra-procedural imaging for the mitral and tricuspid PASCAL Repair System (2021) (5)
Atrial Fibrillation and Outcomes After Transcatheter or Surgical Aortic Valve Replacement (From the PARTNER 3 Trial). (2021) (5)
Transcatheter Aortic Valve Replacement. (2018) (5)
First dedicated transcatheter leaflet splitting device: the ShortCut device. (2022) (5)
THE IMPACT OF SIX–MINUTE WALK TEST PERFORMANCE ON OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: INSIGHTS FROM THE PARTNER TRIAL (2013) (5)
ANALYSIS OF THE INITIAL UNITED STATES EXPERIENCE WITH THE BIOTRACE TEMPO TEMPORARY PACING LEAD IN TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) AND OTHER CARDIAC PROCEDURES (2018) (5)
Mortality risk after transcatheter aortic valve implantation: analysis of the predictive accuracy of the Transcatheter Valve Therapy registry risk assessment model. (2018) (5)
TCT-37 Transcatheter Aortic Valve Replacement with a Repositionable Self-expanding Bioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-Year Results from the Evolut R US Pivotal Study. (2016) (4)
Atrial Fibrillation and Transcatheter Aortic Valve Replacement: The Burden of Advanced Cardiovascular Disease in Aortic Stenosis. (2015) (4)
Abstract 13456: Screening for Transthyretin Cardiac Amyloidosis Using 99mTc-Pyrophosphate Scintigraphy in Patients Undergoing Transcatheter Aortic Valve Replacement (2015) (4)
INCIDENCE, PREDICTORS AND IMPACT OF BLEEDING EVENTS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) COMPARED TO SURGICAL AORTIC VALVE REPLACEMENT (SAVR): INSIGHTS FROM THE PARTNER TRIAL (2012) (4)
A stepwise progression in the treatment of cardiogenic shock. (2012) (4)
Perivalvular Extension of Infective Endocarditis after Transcatheter Aortic Valve Replacement. (2021) (4)
Partial Flow with 15F Arterial Cannula Provides Sufficient Circulatory Support in Veno-Arterial Extracorporeal Membrane Oxygenation (2014) (4)
Commissural Alignment After Transfemoral Transcatheter Aortic Valve Replacement With the JenaValve Trilogy System. (2021) (4)
TCT-672 Outcomes in the Commercial Use of Self-expanding Prostheses in Transcatheter Aortic Valve Replacement: A Comparison of the Medtronic CoreValve and Evolut R platforms in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryTM. (2016) (4)
Impact of inferior vena cava entry characteristics on tricuspid annular access during transcatheter interventions (2022) (4)
Atrial Fibrillation Is Associated With Mortality in Intermediate Surgical Risk Patients With Severe Aortic Stenosis: Analyses From the PARTNER 2A and PARTNER S3i Trials (2021) (4)
Impact of small prosthesis size on transcatheter or surgical aortic valve replacement outcomes (2018) (4)
Sex-Related Characteristics and Short-Term Outcomes of Patients Undergoing Transcatheter Tricuspid Valve Intervention for Tricuspid Regurgitation. (2022) (4)
Transcatheter Tricuspid Valve Intervention in Patients with Previous Left Valve Surgery. (2021) (4)
Three-year outcomes with a contemporary self-expanding transcatheter valve from the Evolut PRO US Clinical Study. (2020) (4)
Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies. (2022) (4)
Burden of Valvular Heart Diseases in Hispanic/Latino Individuals in the United States: The Echocardiographic Study of Latinos. (2019) (4)
Impact of Right Ventricle-Pulmonary Artery Coupling on Clinical Outcomes in the PARTNER 3 Trial. (2022) (4)
Long‐Term Outcomes of Transcatheter Aortic Valve Replacement in Patients With End‐Stage Renal Disease (2021) (3)
In‐hospital outcomes of transcatheter versus surgical aortic valve replacement in non‐teaching hospitals (2018) (3)
Early outcomes from the CLASP IID trial roll‐in cohort for prohibitive risk patients with degenerative mitral regurgitation (2021) (3)
1-Year Outcomes of Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study. (2022) (3)
Left ventricular injury: Beware the wire (2020) (3)
Propensity-Matched Comparison of Evolut-R Transcatheter Aortic Valve Implantation With Surgery in Intermediate-Risk Patients (from the SURTAVI Trial). (2020) (3)
Utilization, Costs, and Outcomes of Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement (2021) (3)
TCT-306 Transcatheter Aortic Valve Replacement with Extremely Large Annuli Greater Than 683 mm2 Using Edwards Sapien 3 Valve – A Multicenter Experience (2017) (3)
Right Heart Morphology of Candidate Patients for Transcatheter Tricuspid Valve Interventions (2021) (3)
Treatment Patterns, Disparities, and Management Strategies Impact Clinical Outcomes in Patients with Symptomatic Severe Aortic Regurgitation (2021) (3)
Three‐year survival of transcatheter versus surgical aortic valve replacement in dialysis (2022) (3)
A RANDOMIZED COMPARISON OF VASCULAR COMPLICATIONS AFTER TAVR COMPARING THE SAPIEN VERSUS THE LOWER-PROFILE SAPIEN-XT SYSTEM IN ‘INOPERABLE’ AORTIC STENOSIS PATIENTS: A PARTNER 2 SUBSTUDY ANALYSIS (2014) (3)
Valve thrombosis after transcatheter and surgical aortic valve replacement: Incidence and outcomes. (2021) (3)
Response to Letters Regarding Article, "Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry". (2015) (3)
Minimally Invasive versus Full Sternotomy for Isolated Aortic Valve Replacement in Low-risk Patients. (2021) (3)
The “Eyeball Test” for Risk Assessment in Aortic Stenosis: Characterizing Subjective Frailty Using Objective Measures (2018) (3)
2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Annular Calcification, Rings, and Bioprostheses. (2022) (3)
Changing the Conversation to TAVR First!: Aftermath of the Low-Surgical Risk TAVR Studies. (2019) (3)
5-Year Outcomes Comparing Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Chronic Kidney Disease. (2021) (3)
Immediate, same-setting paravalvular leak closure following transcatheter aortic valve replacement. (2015) (3)
Comparison of Clinical and Echocardiographic Outcomes After Transcatheter Aortic Valve Implantation With 31-mm CoreValve Versus 34-mm Evolut R Bioprostheses from the STS/ACC TVT Registry. (2019) (3)
Transcatheter mitral valve-in-ring with the Melody prosthesis: a new therapeutic opportunity. (2014) (3)
Treatment of Acute Aortic Insufficiency With a Dedicated Device (2021) (3)
TCT-691 Sex-Specific Differences After Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients: An Analysis from the PARTNER 2 Randomized Trial. (2016) (3)
TCT-114 Impact of Left Ventricular Function on Outcomes of Transcatheter Aortic Valve Replacement and Medical Therapy in Inoperable Patients with Aortic Stenosis: Insights from the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort B) (2013) (2)
Beyond the Valve and into the Muscle: A Review of Coexisting Aortic Stenosis and Transthyretin Cardiac Amyloidosis (2019) (2)
Subclinical Leaflet Thrombosis and Anticoagulation After Transcatheter Aortic Valve Replacement: A Review. (2022) (2)
Association Between Early Left Ventricular Ejection Fraction Improvement After Transcatheter Aortic Valve Replacement and 5-Year Clinical Outcomes. (2022) (2)
THE ROLE OF PRIOR BALLOON AORTIC VALVULOPLASTY IN PATIENTS UNDERGOING TAVR: A PARTNER I SUBSTUDY ANALYSIS (2014) (2)
CLINICAL IMPACT OF NEW LEFT BUNDLE BRANCH BLOCK IN INTERMEDIATE RISK PATIENTS UNDERGOING TAVR: AN ANALYSIS OF THE PARTNER II TRIAL AND REGISTRIES (2018) (2)
Transcatheter Edge-to-Edge Repair in Patients With Anatomically Complex Degenerative Mitral Regurgitation. (2023) (2)
Transcatheter trans-septal mitral valve-in-valve implantation. (2018) (2)
TCT-38 Self-Expanding TAVR for Treatment of Aortic Insufficiency: An Analysis of the STS/ACC TVT Registry (2017) (2)
First-in-Human Dedicated Leaflet Splitting Device for Prevention of Coronary Obstruction in Transcatheter Aortic Valve Replacement. (2023) (2)
Response to Letter Regarding Article, "Long-Term Outcomes of Inoperable Patients With Aortic Stenosis Randomly Assigned to Transcatheter Aortic Valve Replacement or Standard Therapy". (2015) (2)
RADIATION EXPOSURE DURING TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) PROCEDURES (2011) (2)
Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses: Insights from the PARTNER II Valve-in-Valve Registry on Utilizing Baseline Computed-Tomographic Assessment (2017) (2)
Mitral Valve Infective Endocarditis after Trans-Catheter Aortic Valve Implantation. (2022) (2)
5-YEAR DURABILITY RESULTS OF TRANSCATHETER MITRAL VALVE REPAIR WITH THE MITRACLIP® SYSTEM IN PATIENTS WITH SEVERE DEGENERATIVE MITRAL REGURGITATION AND PROHIBITIVE SURGICAL RISK (2018) (2)
3 YEAR OUTCOMES OF TRANSCATHETER MITRAL VALVE-IN-VALVE, VALVE-IN-RING AND VALVEIN-MITRAL ANNULAR CALCIFICATION: RESULTS FROM THE MITRAL TRIAL (2022) (2)
EARLY OUTCOMES WITH THE EVOLUT R REPOSITIONABLE SELF-EXPANDING TRANSCATHETER AORTIC VALVE IN THE UNITED STATES (2016) (2)
30 DAY OUTCOMES FROM THE PARTNER II TRIAL FOR TRANSAPICAL AND TRANSFEMORAL 29MM TAVR IN INOPERABLE PATIENTS WITH THE EDWARDS SAPIEN XT (2014) (2)
ATRIAL FIBRILLATION IS ASSOCIATED WITH INCREASED MORTALITY IN PATIENTS UNDERGOING TAVR: INSIGHTS FROM THE PARTNER TRIAL (2014) (2)
Bleeding Outcomes in Patients Undergoing Combined Percutaneous Coronary Interventions+Transcatheter Aortic Valve Replacement: Time for an Adjustment to the CathPCI Bleeding Model? (2020) (2)
Prognostic implications of baseline 6‐min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement (2020) (2)
TCT-74 SCOUT Study: Trialign results at 30 days from combined US and EU cohort for the treatment of functional TR (2018) (2)
Abstract 23085: 30-Day Outcomes of Transseptal Transcatheter Mitral Valve Replacement for Failed Surgical Bioprostheses (Mitral Valve-in-Valve): The MITRAL Trial (Mitral Implantation of TRAnscatheter vaLves) (2017) (2)
Outcomes of Patients with Significant Obesity Undergoing TAVR or SAVR in the Randomized PARTNER 2A Trial (2018) (2)
Disarming the Ticking Time Bomb: Post-Procedure Electrocardiography Predictors of High-Degree Conduction Disturbances After Transcatheter Aortic Valve Replacement. (2018) (2)
Patient-Specific Computer Simulation to Optimize Transcatheter Heart Valve Sizing and Positioning in Bicuspid Aortic Valve (2021) (2)
Infective Endocarditis Caused by Staphylococcus Aureus after Transcatheter Aortic Valve Replacement. (2021) (2)
Neutrophil‐to‐Lymphocyte Ratios in Patients Undergoing Aortic Valve Replacement: The PARTNER Trials and Registries (2022) (2)
THE IMPORTANCE OF VASCULAR COMPLICATIONS AFTER TRANS-FEMORAL TRANS-CATHETER AORTIC VALVE REPLACEMENT (TAVR): INSIGHTS FROM THE PARTNER TRIAL (2012) (2)
IMPACT OF PREOPERATIVE MODERATE/SEVERE MITRAL REGURGITATION ON PATIENTS UNDERGOING PERCUTANEOUS AND SURGICAL AORTIC VALVE REPLACEMENT: INSIGHTS FROM THE PARTNER TRIAL (2013) (2)
Abstract 23079: Clinical Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Mitral Valve-in-Valve) and Surgical Rings (Mitral Valve-in-Ring) in the United States: Data From the STS/ACC/TVT Registry (2017) (2)
Incidence and Severity of Paravalvular Aortic Regurgitation With Multidetector Computed Tomography Nominal Area Oversizing or Undersizing After Transcatheter Heart Valve Replacement With the Sapien 3 A (2017) (2)
Impact of paravalvular leak following transcatheter aortic valve replacement on one-year mortality: analysis of the combined PARTNER cohorts (2013) (2)
TCT-93 Results From the Early Feasibility Study of Cardioband Tricuspid System for Functional Tricuspid Regurgitation (2019) (2)
Transthoracic access for transcatheter aortic valve replacement: technique using the Edwards Sapien Retroflex delivery system. (2014) (2)
TCT-674 Sex Specific Outcomes of TAVR with the Sapien 3 Valve: Insights From The PARTNER 2 S3 High-Risk and Intermediate-Risk Cohorts. (2016) (2)
Transcatheter valve-in-valve implantation for early prosthetic valve degeneration in aortic and mitral positions. (2014) (2)
Transcatheter versus Surgical Aortic Valve Replacement in Patients with Moderate to Severe Chronic Kidney Disease: A Systematic Review and Analysis (2018) (2)
Health Services and Outcomes Research Cost-Effectiveness of Transcatheter Aortic Valve Replacement Compared With Standard Care Among Inoperable Patients With Severe Aortic Stenosis (2012) (2)
Urgent transcatheter aortic valve replacement for severe acute aortic regurgitation following open mitral valve surgery (2019) (2)
COSTS OF PERIPROCEDURAL COMPLICATIONS IN PATIENTS TREATED WITH TRANSCATHETER AORTIC VALVE REPLACEMENT: RESULTS FROM THE PARTNER TRIAL (2014) (2)
Transcatheter Aortic Valve Replacement With Self‐Expandable Supra‐Annular Valves for Degenerated Surgical Bioprostheses: Insights From Transcatheter Valve Therapy Registry (2021) (2)
TCT-4 Transcatheter Tricuspid Valve Repair in Patients With Functional Tricuspid Regurgitation: 2-Year Outcomes From the FORMA US Early Feasibility Study (2019) (1)
Association of Mild Valvular Lesions With Long-term Cardiovascular Outcomes Among Black Adults (2022) (1)
ANTITHROMBOTIC THERAPY AND CARDIOVASCULAR RISK IN PATIENTS WITH ATRIAL FIBRILLATION AT HIGH RISK FOR THROMBOEMBOLIC EVENTS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: FROM THE PARTNER 2 TRIAL (2019) (1)
TCT-112 Left Ventricular Ejection Fraction Improves Less after Trans-Apical Transcatheter Aortic Valve Replacement Compared to a Trans-Femoral Approach (2013) (1)
TCT-347 Neurologic Events in Patients Treated with Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement: Insights from the PARTNER (Placement of Aortic Transcatheter Valves) Trial (2017) (1)
CHARACTERIZING AND QUANTIFYING MITRAL ANNULAR CALCIFICATION FOR PATIENT-PREDICTIVE MODELING IN THE ERA OF TMVR (2020) (1)
TCT-375 Current Generation Balloon-Expandable Transcatheter Valve Positioning During Aortic Valve-in-Valve Procedures and Clinical Outcomes (2018) (1)
TCT-95 Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Women: Insights from the Randomized PARTNER Trial (2012) (1)
ACUTE KIDNEY INJURY FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT IS ASSOCIATED WITH AN INCREASED RISK OF CHRONIC KIDNEY DISEASE AT 1 YEAR (2014) (1)
TCT-50 Incidence and Prognostic Significance of Heart Failure Hospitalization After Transcatheter or Surgical Aortic Valve Replacement: Results From the PARTNER Trials (2021) (1)
TAVR After Prior Mitral Valve Surgery: Results from the Transcatheter Valve Therapy Registry. (2020) (1)
Incidence and predictors of cardiogenic shock following surgical or transcatheter tricuspid valve intervention (2022) (1)
Transcatheter aortic valve implantation: Clinical outcomes (2012) (1)
In-Hospital Outcomes of Tricuspid Transcatheter Tricuspid Valve Repair: An Analysis From the National Inpatient Sample (2022) (1)
When Excluded From Randomized Clinical Trials: To "OR" or "'TAVR"? (2021) (1)
NATIONAL TRENDS OF PERMANENT PACEMAKER IMPLANTATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: AN ANALYSIS FROM THE STS/ACC TVT REGISTRY (2021) (1)
TCT CONNECT-468 Postoperative Atrial Fibrillation or Flutter Following Transcatheter or Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients at Low Surgical Risk: An Analysis From the PARTNER 3 Trial (2020) (1)
Impact of Short-Term Complications on Mortality and Quality of Life after TAVR (2019) (1)
Clinical and Functional Outcomes Associated With Myocardial Injury After€Transfemoral and Transapical Transcatheter Aortic Valve Replacement (1)
TCT-439 Procedural and 30-Day Outcomes of Patients Undergoing Transcatheter Aortic and Mitral Valve Replacements (2019) (1)
Suprasternal Versus Transfemoral Access for Transcatheter Aortic Valve Replacement: Insights From a Propensity Score Matched Analysis (2021) (1)
Valve in Valve for Failed Surgical Bioprostheses: Not for Everyone! (2018) (1)
Coronary Revascularization in Patients Undergoing Transcatheter Aortic Valve Replacement. (2017) (1)
PREDICTORS OF WORSENING OR PERSISTENT TRICUSPID REGURGITATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (2019) (1)
Prognostic Value of Tricuspid Valve Gradient After Transcatheter Edge-to-Edge Repair: Insights From the TriValve Registry. (2023) (1)
TCT-863 SCOUT 1 Trial: Impact of Center Experience on Intraprocedural and 30 Day Outcomes (2018) (1)
ASSESSMENT OF BALLOON-EXPANDABLE TRANSCATHETER HEART VALVE OVERSIZING USING THREE-DIMENSIONAL TRANSESOPHAGEAL ECHOCARDIOGRAPHY SEMI-AUTOMATION VERSUS. DIRECT PLANIMETRY: ALL METHODS ARE NOT CREATED EQUAL (2016) (1)
A MULTIDISCIPLINARY, MULTIMODALITY, BUT MINIMALIST (3M) APPROACH TO TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT FACILITATES SAFE NEXT DAY DISCHARGE HOME IN HIGH RISK PATIENTS: 1 YEAR FOLLOW UP (2014) (1)
TCT CONNECT-474 Incidence and Impact of Prosthesis–Patient Mismatch after Aortic Valve Replacement in the PARTNER 2 Trial and Registry (2020) (1)
ROUTINE EARLY DISCHARGE AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: A PROPENSITY SCORE ANALYSIS FROM THE PARTNER 2 SAPIEN 3 STUDY (2018) (1)
TRANSTHYRETIN CARDIAC AMYLOIDOSIS IS PREVALENT AMONG MEN WITH SEVERE AORTIC STENOSIS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT (2016) (1)
3D Intracardiac Echocardiography in Mitral Transcatheter Edge-to-Edge Repair (2022) (1)
Urologic Complications in Patients Receiving Indwelling Urinary Catheters During Transcatheter Aortic Valve Replacement. (2020) (1)
Relation between Modified Body Mass Index and Adverse Outcomes after Aortic Valve Implantation. (2021) (1)
Real‐world experience with concomitant or staged transcatheter aortic and mitral valve replacements using balloon‐expandable valves (2022) (1)
CONCENTRIC LEFT VENTRICULAR REMODELING IS ASSOCIATED WITH LOW-FLOW SEVERE AORTIC STENOSIS AND LESS REVERSE REMODELING AFTER TAVR: A PARTNER 2 TRIAL ANALYSIS (2017) (1)
INTRAVASCULAR ULTRASOUND-DERIVED LEFT MAIN MINIMUM LUMEN AREA AND PLAQUE BURDEN PREDICT 12-YEAR CARDIAC MORTALITY (2021) (1)
PROCEDURAL VARIATION IN THE PERFORMANCE OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-ELEVATION MYOCARDIAL INFARCTION: A SURVEY STUDY OF US INTERVENTIONAL CARDIOLOGISTS (2012) (1)
Doppler Velocity Index Outcomes Following Surgical or Transcatheter Aortic Valve Replacement in the PARTNER Trials. (2021) (1)
IMPROVEMENTS IN PHYSICAL ACTIVITY LAG BEHIND IMPROVEMENT IN FUNCTIONAL CAPACITY AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT IN OLDER ADULTS (2012) (1)
Neurocognitive Function Change in Low-Risk Patients Undergoing TAVR Versus SAVR: Insights From PARTNER-3. (2020) (1)
TCT-115 Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience (2013) (1)
1-Year Outcomes of Transcatheter Tricuspid Valve Repair. (2023) (1)
TCT-661 The Clinical Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Replacement: Insights from the PARTNER II SAPIEN 3 Cohort. (2016) (1)
ECG-Independent Calculation of Instantaneous Wave-Free Ratio (2017) (1)
Evolution of definitions and understanding of vascular complications related to transcatheter aortic valve replacement. (2013) (1)
IMPACT OF LEVEL OF ANAESTHESIA USING THE VANCOUVER CLINICAL PATHWAY FOR TRANSCATHETER AORTIC VALVE REPLACEMENT: INSIGHTS FROM THE 3M TAVR STUDY (2018) (1)
NEW PACEMAKER IMPLANTATION AFTER SURGICAL AORTIC VALVE REPLACEMENT IN THE PARTNER TRIALS: RATES, RISK FACTORS, AND CLINICAL OUTCOMES (2018) (1)
1-YEAR RESULTS OF TRANSCATHETER AORTIC VALVE REPLACEMENT IN EXTREMELY LARGE ANNULI >683 MM2 WITH EDWARDS SAPIEN 3 VALVE: A MULTICENTER EXPERIENCE (2019) (1)
IMPACT OF ACUTE KIDNEY INJURY AFTER SURGICAL AND TRANSCATHETER AORTIC VALVE REPLACEMENT IN INTERMEDIATE-RISK PATIENTS WITH CHRONIC KIDNEY DISEASE (2021) (1)
TCT CONNECT-2 The PASCAL Transcatheter Valve Repair System for the Treatment of Tricuspid Regurgitation: 30-Day Outcomes From the CLASP TR Early Feasibility Study (2020) (1)
Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. (2016) (1)
Implications of Left Ventricular Geometry in Low-Flow Aortic Stenosis: A PARTNER 2 Trial Subanalysis. (2019) (1)
EFFECTIVE ORIFICE AREA REFERENCE VALUES WITH THE DIFFERENT SIZES OF THE SAPIEN 3 BALLOON-EXPANDING TRANSCATHETER AORTIC VALVE (2016) (1)
TCT-95 The Long-term Hemodynamic Performance of Transcatheter Aortic Valve Replacement: A Report from the PARTNER I Trial (2015) (1)
POOR OUTCOME AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: ASSOCIATIONS OF MORTALITY AND QUALITY OF LIFE WITH FRAILTY IN THE PARTNER TRIAL (2015) (1)
TCT-42 Impact of Right Ventricle-Pulmonary Artery Coupling on Clinical Outcomes After Transcatheter and Surgical Aortic Valve Replacement: An Analysis of the PARTNER 3 Trial (2021) (1)
TCT CONNECT-497 Incidence and Predictors of Cardiogenic Shock Following Tricuspid Valve Repair or Replacement (2020) (1)
TCT CONNECT-92 Initial Single-Center Experience With Transfemoral Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Regurgitation (2020) (1)
Moderated PosterTAVR EconomicsTCT-242 Cost Savings Associated with Next-day Discharge among US Medicare Beneficiaries Undergoing Transcatheter Aortic Valve Replacement (2017) (1)
Valvular Disease: Role of cardiac surgery support during contemporary TAVI (2016) (1)
TCT-113 Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial (2013) (1)
TCT-839 Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis is More Likely to Improve than Worsen CKD Stage: Analysis of the PARTNER 1, 2A, and S3 Trials (2018) (1)
TCT-97 Transcatheter Aortic Valve Replacement Using the Self-Expanding Bioprosthesis: First Report from the Transcatheter Valve Therapies Registry (2015) (1)
PREDICTORS OF POOR OUTCOME AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT IN THE PARTNER TRIAL (2013) (1)
Coronary Intervention in the Treatment of Patients With Aortic Stenosis Replacement Era : Old Questions , New Paradigms : The Evolving Role of Percutaneous Coronary Artery Disease and Aortic Stenosis in the Transcatheter Aortic Valve (2012) (1)
TCT-758 Age Alone Should Not Preclude Surgery: Contemporary Outcomes after Aortic Valve Replacement in Nonagenarians (2013) (1)
Cardiac Arrest in the Era of Mechanical Circulatory Support: A Single Center Experience with Extracorporeal Cardiopulmonary Resuscitation (2014) (1)
Reasons for lesion uncrossability as assessed by intravascular ultrasound (2022) (1)
SEX–SPECIFIC DIFFERENCES IN LATE MORTALITY AFTER TRANSCATHETER AVR IN THE PARTNER TRIAL (2013) (1)
TCT-225 Impact of frailty on a minimalist approach and early discharge following TAVR: insights from the 3M TAVR Study (2018) (1)
Characteristics and clinical outcomes in patients with prior chest radiation undergoing TAVR: Observations from PARTNER‐2 (2022) (1)
30 DAY RESULTS OF THE SCOUT I STUDY IN PATIENTS WITH SEVERE TRICUSPID REGURGITATION (TR) (2018) (0)
TCT-752 Incidence and Outcomes of Patient-Prosthesis Mismatch Following Self-Expanding Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry (2019) (0)
TCT CONNECT-1 Early Feasibility Study of the Cardioband Tricuspid System for Functional Tricuspid Regurgitation: 30-Day Outcomes (2020) (0)
CLINICAL IMPLICATIONS OF NEW LEFT BUNDLE BRANCH BLOCK: SUB–ANALYSIS FROM THE PARTNER TRIAL (2013) (0)
TCT-395 A Propensity-Matched Comparison of Suprasternal and Transfemoral Transcatheter Aortic Valve Replacement: Inominate versus Femoral (2018) (0)
Faculty of 1000 evaluation for Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. (2018) (0)
TCT-759 Correlates for Device Malposition during Aortic Valve-in-Valve Implantation: Insights from the Global Valve-in-Valve Registry (2013) (0)
Multi-Modality Imaging in a Hybrid Setting Facilitates Transcatheter Closure of a Traumatic Ventricular Septal Defect (2013) (0)
PREVENTION OF CARDIAC MATERNAL MORTALITY IN THE DEVELOPING WORLD: SCREENING PREGNANT WOMEN IN HYDERABAD, INDIA FOR STRUCTURAL HEART DISEASE (2020) (0)
Simulations of transcatheter aortic valve implantation: implications for aortic root rupture (2014) (0)
Abstract 18420: Does Maximum 10-hour Daily Activity From Objective Activity Monitoring Correlate With Self-reported or Performance-based Function in Older Adults With Severe Aortic Stenosis? (2015) (0)
REFINING THE CLASSIFICATION OF SEVERE, SYMPTOMATIC AORTIC STENOSIS USING FLOW AND GRADIENT MEASUREMENTS TO PREDICT OUTCOMES POST-TRANSCATHETER AORTIC VALVE REPLACEMENT (2017) (0)
THE EFFECT AND RELATIONSHIP OF AGE AND FRAILTY ON SURVIVAL IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT (2018) (0)
THE EFFECT OF OVERSIZING ON THE HEMODYNAMIC PERFORMANCE OF THE SAPIEN 3 TRANSCATHETER HEART VALVE (2015) (0)
TCT-663 Anatomic and Procedural Predictors of Paravalvular Leak following Transcatheter Aortic Valve Replacement with a Self-expanding Prosthesis at a High Volume Center Including a Novel Variable of Inflow Expansion (2015) (0)
INCIDENCE AND OUTCOMES OF PATIENTS REQUIRING SURGICAL BAIL-OUT DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: A REPORT FROM THE NCDR® STS/ACC TRANSCATHETER VALVE THERAPY (TVT) REGISTRY (2017) (0)
Aortic Valve Annular Sizing (2017) (0)
TCT-34 Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial. (2016) (0)
TCT CONNECT-494 Importance of Symptom and Activity Improvement for Patients With Tricuspid Regurgitation (TR) (2020) (0)
THE IMPACT OF FRAILTY ON EARLY CHANGES IN PHYSICAL ACTIVITY AFTER TRANSCATHETER TRICUSPID VALVE REPAIR: AN ANALYSIS OF WEARABLE ACTIVITY MONITORING IN THE CLASP TR EARLY FEASIBILITY STUDY (2020) (0)
TCT-398 Associations Between Atrial Fibrillation and Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement With Self-Expanding Devices: Results From the United States STS/ACC TVT Registry (2017) (0)
THE PRESENCE OF A PACEMAKER IS ASSOCIATED WITH INCREASED 1 YEAR MORTALITY AND REHOSPITALIZATION IN THE PARTNER TRIAL (2014) (0)
Fluid Study of Transcatheter Aortic Valve Deployment Into Patients With Varying Coronary Ostia Position (2011) (0)
TAVR AGE PARADOX: THE OLDEST PATIENTS HAVE BETTER THAN EXPECTED OUTCOMES IN THE PARTNER STUDY (2016) (0)
ADDITIONAL STENT EXPANSION WITH POST-DILATATION OF BALLOON EXPANDABLE TRANSCATHETER AORTIC VALVE (2012) (0)
TCT-138 Right Ventricular Remodeling and Clinical Outcomes Following Transcatheter Tricuspid Valve Intervention (2021) (0)
Trans-septal puncture, septal dilatation, and valve crossing, valve placement, valve deployment (2021) (0)
TCT-93 Relationship of Transcatheter and Surgical Aortic Valve Replacement with Left Ventricular Function in High-Risk Patients with Aortic Stenosis (2012) (0)
TCT-744 Quantitative Assessment of Balloon-Expandable Valve Position During Transcatheter Aortic Valve Replacement Using Intraoperative Transesophageal Echocardiography (2013) (0)
TRANSCATHETER AORTIC VALVE REPLACEMENT IN ONCOLOGY PATIENTS WITH AORTIC STENOSIS (2018) (0)
TCT CONNECT-347 Overexpansion of Balloon-Expandable Aortic Transcatheter Heart Valves in the Mitral Valve Position (2020) (0)
TRENDS IN TRANSCATHETER AND SURGICAL AORTIC VALVE REPLACEMENT AMONG MEDICARE BENEFICIARIES IN THE UNITED STATES, 2012-2017 (2020) (0)
Evolution of Transcatheter Valve Therapy for Aortic Stenosis. (2018) (0)
Abstract 18371: Regression of LV Mass After Transcatheter or Surgical Aortic Valve Replacement for Aortic Stenosis in the PARTNER I Trial (2013) (0)
CRT-800.11 New Pacemaker Implantation Does Not Impact Mortality after Transcatheter Aortic Valve Replacement with a Self-expanding Bioprosthesis: Results from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryTM (2017) (0)
Emergent Transcatheter Aortic Valve Replacement for Aortic Insufficiency. (2018) (0)
Transfemoral TAVR: Balloon-Expandable Valves (2016) (0)
Transcatheter Tricuspid Valve Replacement With Novel Self-Expanding Valve: Secure Fixation in Insecure Anatomy. (2023) (0)
Impact of Resting Heart Rate at 30 Days Following Transcatheter or Surgical Aortic Valve Replacement and Cardiovascular Outcomes: Insights from The PARTNER 2 Trial (2018) (0)
EARLY IMPROVEMENT IN FLOW (LEFT VENTRICULAR STROKE VOLUME INDEX) AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT IS ASSOCIATED WITH IMPROVED SURVIVAL IN LOW-FLOW AORTIC STENOSIS (2015) (0)
TCT-474 Ultra-Low Contrast Coronary Angiography in Patients with Advanced Chronic Kidney Disease - Feasibility and Outcomes Compared to Standard Angiography (2017) (0)
Abstract TP483: Transcatheter Aortic Valve Replacement (TAVR) Does Not Improve Cerebral Hemodynamics or Neurocognition in Patients With Severe Aortic Stenosis (2020) (0)
TCT-265 Impact of Peri-procedural Complications on Mortality and Quality of Life after TAVR (2017) (0)
TCT-614 Simulated Neo-Left Ventricular Outflow Tract predicts Transvalvular Aortic Gradients Following Transatrial Balloon-Expandable Valve Replacement for the Treatment of Severe Mitral Annular Calcification (2017) (0)
AUTHORIZATION FOR INSURANCE CLAIM APPEALS (2013) (0)
IMPACT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON TRANSCATHETER AND SURGICAL AORTIC VALVE REPLACEMENT: FROM THE PARTNER 2 COHORT A TRIAL (2019) (0)
TCT-891 Outcomes Of Transcatheter Aortic Valve Replacement Versus Standard Therapy Among Women Deemed Too High Risk For Surgery In The PARTNER Trial (2012) (0)
EARLY IMPROVEMENT IN PULMONARY HYPERTENSION AND RIGHT VENTRICULAR FUNCTION IN TRANSCATHETER COMPARED TO SURGICAL AORTIC VALVE REPLACEMENT (2014) (0)
TCT-538 Bleeding Outcomes in Patients Undergoing Combined TAVR/PCI: Time for an Adjustment to the CathPCI Bleeding Model? (2018) (0)
TCT-471 First-in-Human Study Results With the Novel Anteris DurAVRTM Three-Dimensional Single-Piece TAVR Device (2022) (0)
ACCELEROMETER-MEASURED PHYSICAL ACTIVITY RECOVERY IN THE FIRST MONTH AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (2012) (0)
TCT-699 Anatomic Deployment Index: A Novel Measure of SAPIEN 3 Transcatheter Heart Valve Performance. (2016) (0)
TCT-3 Modified Body Mass Index, A Novel Marker of Malnutrition and Clinical Frailty, is Associated With Outcomes After Transcatheter and Surgical Aortic Valve Replacement (2019) (0)
Transcatheter Aortic Valve Replacement in Large Annuli Valves With the Supra-Annular, Self-Expandable Evolut Platform in a Real-World Registry (2023) (0)
TCT-51 Impact of anticoagulation therapy on valve hemodynamics and clinical outcomes after bioprosthetic aortic valve replacement: A pooled analysis of the PARTNER2 trials (2017) (0)
ACHIEVEMENT OF GUIDELINE DIRECTED MEDICAL THERAPY GOALS IN COMPLEX HIGHER-RISK (AND INDICATED) PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2019) (0)
Modeling Left Ventricular Blood Flow Using Smoothed Particle Hydrodynamics (2017) (0)
Reply: Looking for the Most Effective Transcatheter Treatment for Tricuspid Regurgitation: A Long Road. (2021) (0)
Endovascular eSheath Predilation to Facilitate Transfemoral Transcatheter Aortic Valve Delivery. (2022) (0)
TCT-145 Temporal Trends and Hospital Variation in Pacemaker Implantation Following TAVR—Insights From the STS/ACC TVT Registry (2021) (0)
TAVR under 70: is age just a number? (2022) (0)
REDUCED BASELINE EJECTION FRACTION IS ASSOCIATED WITH INCREASED CARDIOVASCULAR MORTALITY AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: RESULTS FROM THE PARTNER II TRIALS (2018) (0)
IMPACT OF ANNULAR OVERSIZING ON PARAVALVULAR REGURGITATION AND VALVE HEMODYNAMICS: NEW INSIGHTS FROM THE PARTNER 3 TRIAL (2021) (0)
TCT-898 Incidence and Impact of Acquired Thrombocytopenia on Bleeding Events and Mortality after Transcatheter Aortic Valve Replacement (TAVR) (2012) (0)
TCT-447 Improved Outcomes in Patients with Bicuspid Aortic Valve Disease with Evolut R Self-Expanding Transcatheter Aortic Valve Replacement: A Report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryTM (2017) (0)
Iatrogenic Atrial Septal Defects After Transseptal Transcatheter Mitral Valve Replacement With a Balloon-Expandable Valve. (2023) (0)
TCT-134 Current Management and Disparities in Care for Patients With Symptomatic Severe Aortic Regurgitation (2019) (0)
Use of Routine Echocardiographic Screening for Structural Heart Disease in At-Risk Pregnant Women in India. (2020) (0)
TCT-255 Net Adverse Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement With a History of Remote, Recent, or Concurrent Percutaneous Coronary Intervention (2021) (0)
TCT-860 Comparison Between Cardiac Computed Tomography and Three-Dimensional Echocardiography for the Evaluation of Patients with Severe Tricuspid Regurgitation (2017) (0)
1132-163 Ventricular synchrony as determined by phase analysis correlates with ejection fraction (2004) (0)
PROGNOSTIC IMPLICATIONS OF DISCHARGE PATTERNS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (2019) (0)
INSIGHTS INTO TIMING, RISK FACTORS, AND OUTCOMES OF NEUROLOGIC EVENTS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT IN THE PARTNER-I TRIAL (2015) (0)
A Meaningful Therapy to Reduce Ischemic Brain Injury (2017) (0)
INITIAL USE OF THE EVOLUT PRO SELF-EXPANDING TRANSCATHETER AORTIC VALVE (2017) (0)
Abstract 12999: Correcting the Current: Modeling the Hemodynamic Impact of Transcatheter Aortic Valve Replacement in Multiple Valvular Heart Disease Precipitating Cardiogenic Shock (2020) (0)
SEX- AND RACE-BASED DIFFERENCES AMONG MEDICARE BENEFICIARIES UNDERGOING TRANSCATHETER AND SURGICAL AORTIC VALVE REPLACEMENT IN THE UNITED STATES, 2012-2017 (2020) (0)
TCT-16 Incidence, Outcomes, and Microbiologic Profile of Prosthetic Valve Endocarditis after TAVR and SAVR: Insights from PARTNER (2018) (0)
TCT-665 Association of Paravalvular Leak after Transcatheter Aortic Valve Replacement with Readmission for Acute Heart Failure: An Analysis from PARTNER 1. (2016) (0)
INCIDENCE AND IMPACT OF ACUTE KIDNEY INJURY (AKI) POST TRANS-CATHETER AORTIC VALVE REPLACEMENT (TAVR) USING THE NEW VALVE ACADEMIC RESEARCH CONSORTIUM (VARC) CRITERIA (2012) (0)
TCT-707 Three-dimensional Echocardiographic Annular Sizing is Associated with Reduced Rates of Post-dilatation (2013) (0)
TCT-106 Atrial Fibrillation is Associated with Increased Mortality in Intermediate-Risk Patients Undergoing TAVR or SAVR: Insights From the PARTNER 2A and PARTNER 2 S3i Trials (2017) (0)
Reconstructive Modeling to Identify Patients At-Risk for Coronary Occlusion Still Eligible for Transcatheter Aortic Valve Replacement An of the (2019) (0)
Transcatheter aortic valve replacement for native aortic valve stenosis with intentional aortic leaflet laceration & salvage coronary intervention (2020) (0)
TCT-506 First Dedicated Leaflet Splitting Device for Prevention of Coronary Obstruction in Transcatheter Aortic Valve Replacement: From Bench Evaluation to First-in-Human Procedures (2022) (0)
TCT-489 Use of a Percutaneous Left Ventricular Assist Device for Patients with Cardiogenic Shock (2018) (0)
Insights from a clinical heart valve centre: characteristics and management of functional mitral regurgitation (2022) (0)
Contents (2020) (0)
Innovation for Patients with Aortic Stenosis (2014) (0)
Abstract 20549: Patient-Specific CT Image-Based Engineering Analysis of Transcatheter Aortic Valve Replacement - Implications for Aortic Root Rupture (2014) (0)
OUTCOMES OF INOPERABLE PATIENTS UNDERGOING TRANSAPICAL AND TRANSAORTIC TRANSCATHETER AORTIC VALVE REPLACEMENT: A PARTNER 2B SUBSTUDY ANALYSIS OF NESTED REGISTRIES (2014) (0)
Management of significant left main coronary disease before and after trans‐apical transcatheter aortic valve replacement in a patient with severe and complex arterial disease (2013) (0)
Abstract 16708: Valvular Disease in Hispanics (2016) (0)
INTRAVASCULAR ULTRASOUND MECHANISMS OF IN-STENT RESTENOSIS IN SAPHENOUS VEIN GRAFT LESIONS (2018) (0)
OUTCOMES AFTER TRANSFEMORAL TAVR FROM THE NON–RANDOMIZED CONTINUED ACCESS REGISTRY OF THE PARTNER TRIAL (2013) (0)
OUTCOMES OF CONCOMITANT TRANSCATHETER AORTIC VALVE REPLACEMENT AND PERCUTANEOUS CORONARY INTERVENTION IN HIGH-RISK PATIENTS WITH SEVERE AORTIC STENOSIS AND OBSTRUCTIVE CORONARY ARTERY DISEASE (2015) (0)
600.12 Comparison of Clinical and Echocardiographic Measures After Transcatheter Aortic Valve Replacement with the 31 Mm CoreValve or 34 Mm Evolut R Bioprostheses: An Analysis of the STS/ACC TVT Registry (2019) (0)
Transcatheter trans-septal mitral valve-in-valve implantation (2018) (0)
TCT-181 Early Changes in Quality of Life after Transcatheter Aortic Valve Replacement: Results from the 3M-TAVR Trial (2018) (0)
Abstract 15617: Atrial Fibrillation Prevalence, Anticoagulation Practices, and Long-term Outcomes for Patients Discharged With Atrial Fibrillation After Tavr: Results From the Partner 2a and S3i Trials (2020) (0)
PATTERNS OF LEFT VENTRICULAR REMODELING IN PATIENTS WITH SEVERE AORTIC STENOSIS IN THE PARTNER TRIAL (2014) (0)
Key Issues in Transcatheter Aortic Valve Replacement (2015) (0)
TCT-77 Association of Residual Mitral Regurgitation after Transcatheter Aortic Valve Replacement with Readmission for Acute Heart Failure: An Analysis from PARTNER 1. (2016) (0)
TCT-116 Prosthesis-Patient Mismatch after Aortic Valve-In-Valve Implantation: Insights from the Global Valve-in-Valve Registry (2013) (0)
Coronary protection in transcatheter aortic valve replacement: when, how and critical decision making. (2020) (0)
Cardiac conduction disturbances after transcatheter aortic valve replacement: much remains to be learned. (2014) (0)
AN 86 YEAR OLD WOMAN WITH RECURRENT HEART FAILURE (2018) (0)
TCT-709 Hemodynamic Outcomes of Post-dilatation in Transcatheter Aortic Valve Replacement (2013) (0)
COMMISSURAL ALIGNMENT AFTER TRANSFEMORAL DELIVERY OF THE JENAVALVE TRANSCATHETER AORTIC VALVE (2021) (0)
DOES PATIENT PROSTHESIS MISMATCH DEFINED BY CT LVOT AREA PREDICT DOWNSTREAM CLINICAL OUTCOMES (2017) (0)
TCT-38 Paravalvular Regurgitation Regression and Impact on 1-year Outcomes After Transcatheter Aortic Valve Replacement with the SAPIEN 3 Transcatheter Valve. (2016) (0)
1132-164 Echocardiographic phase analysis: Timing of the cardiac cycle using left atrial motion (2004) (0)
TCT-39 Clinical Outcomes in SURTAVI Based on Revascularization Stratification (2017) (0)
The Inflammatory Infiltrate in Calcific Aortic Stenosis is Characterized by Clonal Expansions of T Cells and is Associated with Elevated Proportions of Circulating Activated and Effector Memory CD8 T Cells (2011) (0)
Reply: Entrapped Leads After Transcatheter Tricuspid Valve Replacement. (2021) (0)
Contents (2020) (0)
Percutaneous Aortic Valve Implantation (2015) (0)
TCT-124 Impact of level of anaesthesia using the Vancouver Clinical Pathway for transcatheter aortic valve replacement: Insights from the 3M TAVR Study (2018) (0)
Incidence, Predictors, and Outcomes of Patients Discharged Home Versus Other Medical Facility After Transcatheter or Surgical Aortic Valve Replacement (2021) (0)
TCT-105 Device-to-Annulus Pre-deployment Angle by Intraoperative Transesophageal Echocardiography Predicts Paravalvular Regurgitation following Transcatheter Aortic Valve Replacement (2013) (0)
A new standard of care for inoperable, severe aortic stenosis: implications of the PARTNER trial (2011) (0)
TCT-108 Debris heterogeneity across different valve types captured by a cerebral protection system during TAVR (2017) (0)
TCT-769 Impact of Elliptical Deployment and Under-Expansion at the Annulus on Transcatheter Aortic Valve Performance: A Computational and Experimental Investigation (2013) (0)
Unearthing the Tunnel (2022) (0)
TCT-2 Paravalvular Regurgitation After Transcatheter Aortic Valve Replacement in Moderate-Risk Patients: A Pooled PARTNER 2 Trial and Registry Study (2019) (0)
TCT CONNECT-490 Health Status Improvements Following Transcatheter Tricuspid Repair With the PASCAL Device in the CLASP TR Early Feasibility Study (2020) (0)
TCT-757 A new transcatheter aortic valve design with enhanced durability: prototype design, fabrication and hydrodynamic testing results (2013) (0)
TCT-266 Complications of Indwelling Urinary Catheters In Patients Undergoing Transcatheter Aortic Valve Replacement (2017) (0)
TCT-147 Transcatheter Aortic Valve Replacement in Large Annuli Valves With the Supra-Annular, Self-Expandable Evolut Platform: Insights From the STS/ACC TVT Registry (2021) (0)
TCT-93 Improvement in Renal Function and its Impact on All-cause Mortality after Transcatheter Aortic Valve Replacement (TAVR): Experience from the PARTNER Trial (2015) (0)
TCT CONNECT-82 Prognostic Value of Serial Neutrophil-to-Lymphocyte Ratio in Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement: The PARTNER I-II Trials and Registries (2020) (0)
Tale of a Black Heart! (2021) (0)
A CROSSOVER BALLOON OCCLUSION TECHNIQUE FOR PERCUTANEOUS CLOSURE AFTER TRANS-FEMORAL AORTIC VALVE IMPLANTATION (2010) (0)
Economics of Minimalist Transcatheter Aortic Valve Replacement: Results From the 3M-TAVR Economic Study (2022) (0)
TCT-425 Impact of cerebral protection in aortic stenosis patients treated with transcatheter aortic valve replacement on functional and structural integrity of the brain: results of a combined patient-level analysis of three randomized controlled trials (2017) (0)
Abstract 18221: Flow Characteristics of CoreValve Transcatheter Aortic Valve: Implications for Calculation of Stroke Volume and Effective Orifice Area (2015) (0)
TCT-384 The Myocardial Contraction Fraction Predicts Adverse Events after Aortic Valve Replacement: An Analysis of 3,259 Patients from the Pooled PARTNER 2 Database (2017) (0)
IMPACT OF PERCUTANEOUS CORONARY INTERVENTION WITHIN 6 MONTHS PRIOR TO TRANSCATHETER AORTIC VALVE REPLACEMENT: A MULTICENTER CENTER STUDY WITH CENTRAL ANGIOGRAPHIC CORE LABORATORY ANALYSIS (2014) (0)
ACCURACY OF THE SINGLE-CYCLE LENGTH METHOD FOR CALCULATING AORTIC VALVE AREA IN NON-SINUS RHYTHMS (2014) (0)
COMPARISON BETWEEN THREE-DIMENSIONAL ECHOCARDIOGRAPHY AND COMPUTED TOMOGRAPHY FOR TRICUSPID ANNULUS SIZING: IMPLICATIONS FOR THE GRADING OF TRICUSPID REGURGITATION USING THE QUANTITATIVE DOPPLER METHOD (2018) (0)
TCT-185 Change in Left Ventricular Diastolic Dysfunction After Transcatheter Aortic Valve Replacement and Outcomes in Patients With Severe Aortic Stenosis (2021) (0)
TCT-477 Prevalence and Clinical Impact of Baseline QRS Duration in Patients With Severe Aortic Stenosis Two Years After Aortic Valve Replacement in the PARTNER II Trial (2018) (0)
IMPACT OF PARAVALVULAR REGURGITATION ASSESSED BY A 5-CLASS GRADING SCHEME ON 1-YEAR OUTCOMES IN THE PARTNER-II SAPIEN 3 HIGH RISK / OPERABLE COHORT (2016) (0)
Abstract 3384: Natural History And Predictors Of Improvement Of Mitral Regurgitation After Percutaneous Aortic Valve Replacement. (2007) (0)
Transcatheter aortic valve replacement: The year in review 2016. (2017) (0)
TCT-97 Three-dimensional Echocardiographic Measurements of the Aortic Annulus Predict Paravavular Regurgitation following Transcatheter Aortic Valve Replacement (2012) (0)
Tricuspid Leaflet Gap-Reduction Maneuvers During Transcatheter Tricuspid Valve Repair (2023) (0)
CARDIAC CT PLANNING TO ACHIEVE COMMISSURAL ALIGNMENT WITH THE JENAVALVE TRILOGY TRANSCATHETER AORTIC VALVE DELIVERY SYSTEM (2023) (0)
Determinants and Outcomes of Acute Transcatheter Valve-in-Valve Therapy orEmbolization (0)
TCT-327 Calcium Volume Score on Contrast-Enhanced Computed Tomography Prior to Transcatheter Aortic Valve Replacement: what’s the most accurate threshold cutoff? (2015) (0)
THE IMPACT OF SEVERITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON TRANSCATHETER AORTIC VALVE REPLACEMENT: FROM THE SAPIEN 3 REGISTRY (2019) (0)
IMPROVEMENTS IN PATIENT-REPORTED SLEEP AFTER TRANSCATHETER TRICUSPID VALVE REPAIR (2021) (0)
TCT-422 Pre-procedural white matter lesion burden predicts MRI outcomes in transcatheter aortic valve replacement (TAVR): The Sentinel Trial (2017) (0)
Early outcomes following transatrial transcatheter mitral valve replacement in patients with severe mitral annular calcification. (2022) (0)
Present and Future Challenges in Transcatheter Aortic Valve Replacement (2020) (0)
THE EFFECT OF MEDICAL THERAPY ON TRICUSPID VALVE ANATOMY IN THE EVALUATION OF TRANSCATHETER TREATMENT OF TRICUSPID REGURGITATION (2023) (0)
REDUCTION OF PARA-VALVULAR REGURGITATION WITH POST-DILATATION FOLLOWING BALLOON-EXPANDABLE TRANSCATHETER AORTIC VALVE REPLACEMENT (2012) (0)
Abstract 19137: Trends in Complications and Outcomes of Patients Undergoing Transfemoral Transcutaneous Aortic Valve Replacement: Experience from the PARTNER Continued Access Registry (2014) (0)
Percutaneous Implantation of Valvular Aortic Bioprosthesis: Reconciling the Clinical and Economi Values of an Established Treatment (2013) (0)
TCT-73 The Relative Effects of New Pacemakers Versus Left Bundle Branch Block on Clinical and Echocardiographic Outcomes in the PARTNER Trials (2019) (0)
Finite Element Analysis of Tricuspid Valve Deformation from Multi-slice Computed Tomography Images (2018) (0)
Baseline Characteristics and Clinical Outcomes of a Tricuspid Regurgitation Referral Population. (2023) (0)
Sex-Related Differences in Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe AorticStenosis (0)
Embolic protection for tricuspid valve-in-valve intervention. (2017) (0)
TCT-785 The "Eyeball Test" in Aortic Stenosis: Characterizing Subjective Frailty with Objective Measures (2013) (0)
CARDIAC MATERNAL MORTALITY IN THE DEVELOPING WORLD: SCREENING PREGNANT WOMEN IN HYDERABAD, INDIA FOR STRUCTURAL HEART DISEASE (2021) (0)
Three-Dimensional Intracardiac Echocardiography for Tricuspid Transcatheter Edge-to-Edge Repair (2022) (0)
TCT-654 Risk of Readmission for Acute Heart Failure, Subsequent Readmission, and Mortality Following Transcatheter Aortic Valve Replacement: An Analysis from PARTNER 1. (2016) (0)
Severity of and Recovery From Anemia After Transcatheter Aortic Valve Replacement: An Analysis of the Placement of Aortic Transcatheter Valves Trial and Registries (2022) (0)
Incidence, Predictors, and PrognosticImpact of Late Bleeding Complications After Transcatheter Aortic Valve Replacement (0)
Abstract 4678: Surgical versus Percutaneous Revascularization for the Treatment of Patients With Multivessel Disease in the Setting of Acute Coronary Syndromes: Analysis From the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) Trial (2009) (0)
PREDICTORS OF AORTIC ROOT INJURY DURING BALLOON–EXPANDABLE TRANSCATHETER AORTIC VALVE IMPLANTATION (2013) (0)
LOW AND ELEVATED B-TYPE NATRIURETIC PEPTIDE LEVELS ARE ASSOCIATED WITH INCREASED MORTALITY IN PATIENTS WITH PRESERVED EJECTION FRACTION UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: FROM THE PARTNER 2 TRIAL AND REGISTRIES (2019) (0)
Fluid-structure interaction simulation of transcatheter aortic valve replacement in a patient with bicuspid aortic valve stenosis and mitral regurgitation (2018) (0)
CHARACTERIZATION OF WATCHMAN FLX DEVICE PROTRUSION INTO THE LEFT ATRIUM AND THE IMPLICATIONS FOR FUTURE TRANSCATHETER MITRAL REPLACEMENT (2023) (0)
LEFT VENTRICULAR REMODELING AFTER JENAVALVE TRILOGY TRANSCATHETER AORTIC VALVE REPLACEMENT IN PATIENTS WITH PURE AORTIC REGURGITATION (2022) (0)
THE ALIGNMENT OF TRANSCATHETER AORTIC VALVE NEO-COMMISSURES (ALIGN TAVR) STUDY (2020) (0)
CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS WITH PRIOR CHEST RADIATION UNDERGOING TAVR: OBSERVATIONS FROM THE PARTNER 2 TRIAL AND REGISTRIES (2018) (0)
The impact of pulmonary hypertension on outcomes of transcatheter mitral valve replacement in mitral annular calcification (2022) (0)
Cardiac Computed Tomography Angiography Anatomical Characterization of Patients Screened for a Dedicated Transfemoral Transcatheter Valve System for Primary Aortic Regurgitation (2023) (0)
D-2 | Cardiac Computed Tomography Angiography Anatomical Characterization of Patients with Primary Aortic Regurgitation (2022) (0)
ANNULUS ASSESSMENT PRIOR TO TRANSCATHETER AORTIC VALVE REPLACEMENT: ANNULUS DIMENSIONS MAY NOT BE LARGEST IN MID-SYSTOLE (2016) (0)
STRUCTURAL VALVE DETERIORATION OF TRANSCATHETER VERSUS SURGICAL AORTIC VALVES IN PATIENTS WITH CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE PARTNER 2A TRIAL AND SAPIEN 3 INTERMEDIATE RISK REGISTRY (2021) (0)
30-DAY OUTCOMES OF TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT FOR AORTIC REGURGITATION WITH A NOVEL SELF-EXPANDING PROSTHESIS (2021) (0)
THE MYOCARDIAL CONTRACTION FRACTION IS SUPERIOR TO THE VOLTAGE TO MASS RATIO FOR IDENTIFYING TTR CARDIAC AMYLOID IN PATIENTS UNDERGOING TAVR (2016) (0)
Transcatheter Aortic Valve Replacement. (2023) (0)
CRT-800.08 Avoiding the Learning Curve in Transcatheter Aortic Valve Replacement (2017) (0)
Tips and tricks in acute myocardial infarction (2007) (0)
Balloon-Assisted Perclose Suture Delivery for Large-Bore Vascular Access Closure After Transcatheter Aortic Valve Replacement (2022) (0)
TCT-773 The Prognostic Significance of Changes in B-type Naturetic Peptide (BNP) after Transcatheter Aortic Valve Replacement (TAVR): THE PARTNER I EXPERIENCE (2013) (0)
INCIDENCE OF SEVERE DECLINE IN PLATELET COUNT IN PATIENTS TREATED BY TRANSCATHETER AORTIC VALVE REPLACEMENT AND CLINICAL OUTCOME (2013) (0)
Rehospitalization Events After Aortic Valve Replacement: Insights From the PARTNER Trial (2022) (0)
TCT CONNECT-89 Impact of Pre-Existent Atrial Fibrillation on Clinical Outcomes After Transcatheter or Surgical Aortic Valve Replacement for Severe Aortic Stenosis: An Analysis From the PARTNER 3 Trial (2020) (0)
TCT-102 SAPIEN 3 implantation in failed surgical aortic bioprostheses: Matched comparison and Insights from the Valve-in-Valve International Data (VIVID) Registry (2015) (0)
Abstract 17178: Variability in Pacemaker Implantation in the 3M TAVR Study: Indications, Outcomes and Implications (2019) (0)
HIGH BASELINE VALVULOARTERIAL IMPEDENCE PREDICTS WORSE 1-YEAR OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (2017) (0)
IMPACT OF TRANSCATHETER TRICUSPID VALVE REPAIR ON DAILY PHYSICAL ACTIVITY: AN ANALYSIS OF WEARABLE ACTIVITY MONITORING IN THE CLASP TR EARLY FEASIBILITY STUDY (2020) (0)
Coronary Artery Disease and Aortic Stenosis (2014) (0)
RIGHT ATRIAL PRESSURE IN PULMONARY HYPERTENSION ASSESSMENT IN TRICUSPID REGURGITATION (2023) (0)
ASSOCIATION BETWEEN LEFT VENTRICULAR EJECTION FRACTION IMPROVEMENT AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT AND 5-YEAR SURVIVAL: AN ANALYSIS OF THE PARTNER TRIALS AND REGISTRIES (2021) (0)
FIVE-YEAR OUTCOMES COMPARING SURGICAL VERSUS TRANSCATHETER AORTIC VALVE REPLACEMENT IN INTERMEDIATE-RISK PATIENTS WITH CHRONIC KIDNEY DISEASE (2021) (0)
Interventions for Congenital Atrioventricular Valve Dysfunction: JACC Focus Seminar. (2022) (0)
TCT-104 One-Year Clinical Outcomes Following Open Transatrial Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Susheel K. Kodali?

Susheel K. Kodali is affiliated with the following schools:

University of British Columbia
Columbia University

Susheel K. Kodali's Academic­Influence.com Rankings

Susheel K. Kodali's Degrees

Why Is Susheel K. Kodali Influential?

Susheel K. Kodali's Published Works

Published Works

What Schools Are Affiliated With Susheel K. Kodali?

Susheel K. Kodali's AcademicInfluence.com Rankings